Timothy Muiruri Kinyanjui

Timothy Muiruri Kinyanjui

Auto-generated profile, based on publicly available information

Timothy Muiruri Kinyanjui

Department of Mathematics, University of Manchester, Oxford Road, Manchester, UK

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MKMoses Chapa Kiti
Moses Chapa Kiti
TKTimothy Muiruri Kinyanjui
Timothy Muiruri Kinyanjui
DKDorothy Chelagat Koech
Dorothy Chelagat Koech
PMPatrick K Munywoki
Patrick K Munywoki
GMGraham Francis Medley
Graham Francis Medley
DNDavid James Nokes
David James Nokes
Improved understanding and quantification of social contact patterns that govern the transmission dynamics of respiratory viral infections has utility in the design of preventative and control measures such as vaccination and social distancing. The objective of this study was to quantify an age-specific matrix of contact rates for a predominantly rural low-income population that would support transmission dynamic modeling of respiratory viruses. From the population register of the Kilifi Health and Demographic Surveillance System, coastal Kenya, 150 individuals per age group (50 years) exhibited the highest inter-generational contacts. Rural contact rates were higher than semiurban (18.8 vs 15.6, p = 0.002), with rural primary school students having twice as many assortative contacts as their semiurban peers. This is the first age-specific contact matrix to be defined for tropical Sub-Saharan Africa and has utility in age-structured models to assess the potential impact of interventions for directly transmitted respiratory infections.

14 June 2016 in EPJ Data Science
Verified
Journal Article
Open access
PDF file
MKMoses C Kiti
Moses C Kiti
MTMichele Tizzoni
Michele Tizzoni
TKTimothy M Kinyanjui
Timothy M Kinyanjui
DKDorothy C Koech
Dorothy C Koech
PMPatrick K Munywoki
Patrick K Munywoki
DND James Nokes
D James Nokes
Close proximity interactions between individuals influence how infections spread. Quantifying close contacts in developing world settings, where such data is sparse yet disease burden is high, can provide insights into the design of intervention strategies such as vaccination. Recent technological advances have enabled collection of time-resolved face-to-face human contact data using radio frequency proximity sensors. The acceptability and practicalities of using proximity devices within the developing country setting have not been investigated. We present and analyse data arising from a prospective study of 5 households in rural Kenya, followed through 3 consecutive days. Pre-study focus group discussions with key community groups were held. All residents of selected households carried wearable proximity sensors to collect data on their close (<1.5 metres) interactions. Data collection for residents of three of the 5 households was contemporaneous. Contact matrices and temporal networks for 75 individuals are defined and mixing patterns by age and time of day in household contacts determined. Our study demonstrates the stability of numbers and durations of contacts across days. The contact durations followed a broad distribution consistent with data from other settings. Contacts within households occur mainly among children and between children and adults, and are characterised by daily regular peaks in the morning, midday and evening. Inter-household contacts are between adults and more sporadic when measured over several days. Community feedback indicated privacy as a major concern especially regarding perceptions of non-participants, and that community acceptability required thorough explanation of study tools and procedures. Our results show for a low resource setting how wearable proximity sensors can be used to objectively collect high-resolution temporal data without direct supervision. The methodology appears acceptable in this population following adequate community engagement on study procedures. A target for future investigation is to determine the difference in contact networks within versus between households. We suggest that the results from this study may be used in the design of future studies using similar electronic devices targeting communities, including households and schools, in the developing world context.

21 September 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TKTimothy M. Kinyanjui
Timothy M. Kinyanjui
THThomas A. House
Thomas A. House
MKMoses C. Kiti
Moses C. Kiti
PCPatricia A. Cane
Patricia A. Cane
DNDavid J. Nokes
David J. Nokes
GMGraham F. Medley
Graham F. Medley
Respiratory syncytial virus (RSV) is globally ubiquitous, and infection during the first six months of life is a major risk for severe disease and hospital admission; consequently RSV is the most important viral cause of respiratory morbidity and mortality in young children. Development of vaccines for young infants is complicated by the presence of maternal antibodies and immunological immaturity, but vaccines targeted at older children avoid these problems. Vaccine development for young infants has been unsuccessful, but this is not the case for older children (> 6m). Would vaccinating older children have a significant public health impact? We developed a mathematical model to explore the benefits of a vaccine against RSV. We have used a deterministic age structured model capturing the key epidemiological characteristics of RSV and performed a statistical maximum-likelihood fit to age-specific hospitalization data from a developing country setting. To explore the effects of vaccination under different mixing assumptions, we included two versions of contact matrices: one from a social contact diary study, and the second a synthesised construction based on demographic data. Vaccination is assumed to elicit an immune response equivalent to primary infection. Our results show that immunisation of young children (5–10m) is likely to be a highly effective method of protection of infants (<6m) against hospitalisation. The majority benefit is derived from indirect protection (herd immunity). A full sensitivity and uncertainty analysis using Latin Hypercube Sampling of the parameter space shows that our results are robust to model structure and model parameters. This result suggests that vaccinating older infants and children against RSV can have a major public health benefit.

22 May 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JNJoyce U Nyiro
Joyce U Nyiro
IKIvy K Kombe
Ivy K Kombe
CSCharles J Sande
Charles J Sande
JKJames Kipkoech
James Kipkoech
PKPatience K Kiyuka
Patience K Kiyuka
DND James Nokes
D James Nokes
Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease in early life and a target for vaccine prevention. Data on the age-prevalence of RSV specific antibodies will inform on optimizing vaccine delivery. Archived plasma samples were randomly selected within age strata from 960 children less than 145 months of age admitted to Kilifi County Hospital pediatric wards between 2007 and 2010. Samples were tested for antibodies to RSV using crude virus IgG ELISA. Seroprevalence (and 95% confidence intervals) was estimated as the proportion of children with specific antibodies above a defined cut-off level. Nested catalytic models were used to explore different assumptions on antibody dynamics and estimate the rates of decay of RSV specific maternal antibody and acquisition of infection with age, and the average age of infection. RSV specific antibody prevalence was 100% at age 0-<1month, declining rapidly over the first 6 months of life, followed by an increase in the second half of the first year of life and beyond. Seroprevalence was lowest throughout the age range 5–11 months; all children were seropositive beyond 3 years of age. The best fit model to the data yielded estimates for the rate of infection of 0.78/person/year (95% CI 0.65–0.97) and 1.69/person/year (95% CI 1.27–2.04) for ages 0-<1 year and 1-<12 years, respectively. The rate of loss of maternal antibodies was estimated as 2.54/year (95% CI 2.30–2.90), i.e. mean duration 4.7 months. The mean age at primary infection was estimated at 15 months (95% CI 13–18). The rate of decay of maternal antibody prevalence and subsequent age-acquisition of infection are rapid, and the average age at primary infection early. The vaccination window is narrow, and suggests optimal targeting of vaccine to infants 5 months and above to achieve high seroconversion.

1 January 2017 in Vaccine
Verified
Journal Article
Open access
Wirichada PanngumWirichada Panngum
Wirichada Panngum
TKTimothy Kinyanjui
Timothy Kinyanjui
MKMoses Kiti
Moses Kiti
STSylvia Taylor
Sylvia Taylor
JTJean-François Toussaint
Jean-François Toussaint
LWLisa J. White
Lisa J. White
Respiratory syncytial virus (RSV) is the major viral cause of infant and childhood lower respiratory tract disease worldwide. Defining the optimal target product profile (TPP) is complicated due to a wide range of possible vaccine properties, modalities and an incomplete understanding of the mechanism of natural immunity. We report consensus population level impact projections based on two mathematical models applied to a low income setting. Two structurally distinct age-specific deterministic compartmental models reflecting uncertainty associated with the natural history of infection and the mechanism by which immunity is acquired and lost were constructed. A wide range of vaccine TPPs were explored including dosing regime and uptake, and effects in the vaccinated individual on infectiousness, susceptibility, duration of protection, disease severity and interaction with maternal antibodies and natural induced immunity. These were combined with a range of vaccine implementation strategies, targeting the highest priority age group and calibrated using hospitalization data from Kilifi County Hospital, Kenya. Both models were able to reproduce the data. The impact predicted by the two models was qualitatively similar across the range of TPPs, although one model consistently predicted higher impact than the other. For a proposed realistic range of scenarios of TPP combinations, the models predicted up to 70% reduction in hospitalizations in children under five years old. Vaccine designs which reduced the duration and infectiousness of infection were predicted to have higher impacts. The models were sensitive to the coverage and rate of loss of vaccine protection but not to the interaction between vaccine and maternal/naturally acquired immunity. The results suggest that vaccine properties leading to reduced virus circulation by lessening the duration and infectiousness of infection upon challenge are of major importance in population RSV disease control. These features should be a focus for vaccine development.

26 March 2018 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
TKTimothy Kinyanjui
Timothy Kinyanjui
JMJo Middleton
Jo Middleton
SGStefan Güttel
Stefan Güttel
JCJackie Cassell
Jackie Cassell
JRJoshua Ross
Joshua Ross
THThomas House
Thomas House
In the context of an ageing population, understanding the transmission of infectious diseases such as scabies through well-connected sub-units of the population, such as residential care homes, is particularly important for the design of efficient interventions to mitigate against the effects of those diseases. Here, we present a modelling methodology based on the efficient solution of a large-scale system of linear differential equations that allows statistical calibration of individual-based random models to real data on scabies in residential care homes. In particular, we review and benchmark different numerical methods for the integration of the differential equation system, and then select the most appropriate of these methods to perform inference using Markov chain Monte Carlo. We test the goodness-of-fit of this model using posterior predictive intervals and propagate forward the resulting parameter uncertainty in a Bayesian framework to consider the economic cost of delayed interventions against scabies, quantifying the benefits of prompt action in the event of detection. We also revisit the previous methodology used to assess the safety of treatments in small population sub-units—in this context ivermectin—and demonstrate that even a very slight relaxation of the implicit assumption of homogeneous death rates significantly increases the plausibility of the hypothesis that ivermectin does not cause excess mortality based upon the data of Barkwell and Shields. Our work makes five main contributions. (1) We study a previously under-modelled scenario—transmission of scabies in residential care homes—that is of significant and growing public health importance in the context of an ageing population. (2) We develop a Markov-chain-based modelling framework that accurately captures the disease dynamics in well-connected sub-units such as care homes, but whose use has previously been limited due to computational cost. (3) We demonstrate that appropriate numerical methods (in particular rational Krylov approaches) for the solution of the mechanistic model for transmission of scabies in care homes speeds up evaluation by several orders of magnitude compared to other methods. (4) We demonstrate a Bayesian approach in which the model is fitted to data using computationally-intensive MCMC methods, validated using posterior predictive intervals, and has its uncertainty quantified in forward predictions. (5) We revisit the question of safety of ivermectin using appropriate methods and demonstrate that relaxation of the assumption of homogeneous death rates can make previous influential conclusions on lack of safety unsound.